Fig. 3From: Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introductionMolecular data. The proportion of wild-type and mutant isolates is shown for five loci in each of dhfr and dhps (all trials) and the K13 propeller region (trial 3 only). a–c refer to the three separate trials undertaken, as indicated above each graphBack to article page